InflaRx (IFRX) Other Accumulated Expenses (2019 - 2026)
InflaRx (IFRX) reported Other Accumulated Expenses of $432,718 for Q2 2026, down 100.0% from $409.33 billion a year earlier and down 4.7% from the prior quarter.
Powered by 
Analysis
InflaRx (IFRX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, InflaRx posted Other Accumulated Expenses of $405,550, up 25.9% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $322,229 in FY2024 (-100.0%), $3.1 trillion in FY2023, $150,597 in FY2022 (-4.7%) and $158,104 in FY2021 (+12.6%).
- Five-year quarterly Other Accumulated Expenses spans a low of -$5.49 million in Q3 2024 and a high of $3.1 trillion in Q4 2023.
- The high point for year-over-year Other Accumulated Expenses in five years was Q4 2025 (growth of 29.7%); the low point was Q4 2024 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $454,177 (Q1 2026), $417,838 (Q4 2025) and $399,354 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,128.85 Bn | 1,097.43 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.21 Bn | 554.07 Bn | 17.30 Bn |
| 3 | AbbVie | 505.78 Bn | 478.89 Bn | 12.70 Bn |
| 4 | Merck | 357.64 Bn | 312.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 290.31 Bn | 254.30 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.38 Bn | 239.06 Bn | 12.86 Bn |
| 7 | Amgen | 238.11 Bn | 193.51 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn |
| 10 | InflaRx | 103.70 Mn | -229.91 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 425,214.14 |
| Mar 31, 2026 | 444,577.10 |
| Dec 31, 2025 | 421,673.76 |
| Sep 30, 2025 | 400,750.80 |
| Jun 30, 2025 | 424,079.96 |
| Mar 31, 2025 | 376,498.02 |
| Dec 31, 2024 | 313,791.27 |
| Sep 30, 2024 | 263,924.86 |
| Jun 30, 2024 | 186.68 Bn |
| Mar 31, 2024 | 3.18 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 226,110.44 |
| Mar 31, 2023 | 178,393.52 |
| Dec 31, 2022 | 157,361.25 |
| Sep 30, 2022 | 140,824.11 |
| Jun 30, 2022 | 136,158.78 |
| Mar 31, 2022 | 146,624.10 |
| Dec 31, 2021 | 156,518.68 |
| Sep 30, 2021 | 150,897.39 |
API Access
InflaRx Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();